In-Vitro Diagnostics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

In-Vitro Diagnostics Market to 2027 - Global Analysis and Forecasts By Product & Services (Reagents & Kits, Instruments, Data Management Software, and Services), Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Urinalysis, and Others), Application (Diabetes, Infectious Diseases, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), End User (Hospitals, Laboratories, Academic Institutes, Point-Of-Care Testing, and Others), and Geography

Report Code: TIPBT00002657 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
In vitro diagnostics are examinations performed on samples which include blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Devices can range from simple tests to sophisticated DNA technology which include reagents, control materials, calibrators, kits, software, and related instruments. In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person's DNA to detect genomic variations.

The in-vitro diagnostics market is expected to witness growth at a rapid pace due to increasing geriatric population and related growth in the prevalence of chronic & infectious diseases, rising adoption of fully automated instruments & automation in laboratories, and growing awareness on personalized medicine. Also, development of condition-specific markers & tests, rising significance of companion diagnostics, growth opportunities in emerging countries are offering opportunities in the in-vitro diagnostics market growth.

The "Global In-Vitro Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global in-vitro diagnostics market with detailed market segmentation by product & services, technology, application, and end user. The global in-vitro diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global in-vitro diagnostics market is segmented on the basis of product & services, technology, application, and end user. The product & services segment includes, reagents & kits, instruments, data management software, and services. The technology segment includes, immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, microbiology, hematology, urinalysis, and others. By application, the in-vitro diagnostics market is segmented into diabetes, infectious diseases, oncology, cardiology, autoimmune diseases, nephrology, and others. By end user, the in-vitro diagnostics market is segmented into hospitals, laboratories, academic institutes, point-of-care testing, and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global in-vitro diagnostics market based on product & services, technology, application, and end user. It also provides market size and forecast till 2027 for overall in-vitro diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America dominated the global in-vitro diagnostics market, the largest share is attributed to the presence of government funds, rising use of molecular diagnostics in genetic disorders & cancer screening, and the presence of key players in the region during the forecast period. The Asia Pacific region is predicted to account for the fastest growth during the forecast period, due to increasing healthcare expenditure, rising number of hospitals & clinical diagnostic laboratories in India and China, increasing incidence of chronic and infectious diseases in the region.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key in-vitro diagnostics companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the in-vitro diagnostics market are F. Hoffmann-La Roche Ltd, Danaher, BD, Abbott, Siemens AG, bioMérieux SA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., and Johnson & Johnson Services, Inc. among others.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. IN-VITRO DIAGNOSTICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. In-Vitro Diagnostics Market - By Product & Services
3.2.2. In-Vitro Diagnostics Market - By Technology
3.2.3. In-Vitro Diagnostics Market - By Application
3.2.4. In-Vitro Diagnostics Market - By End User
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. IN-VITRO DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. IN-VITRO DIAGNOSTICS MARKET - GLOBAL ANALYSIS
5.1. IN-VITRO DIAGNOSTICS MARKET OVERVIEW
5.2. IN-VITRO DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT & SERVICES
6.1. OVERVIEW
6.2. PRODUCT & SERVICES MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. REAGENTS & KITS MARKET
6.3.1. Overview
6.3.2. Reagents & Kits Market Revenue Forecasts and Analysis (US$ Mn)
6.4. INSTRUMENTS MARKET
6.4.1. Overview
6.4.2. Instruments Market Revenue Forecasts and Analysis (US$ Mn)
6.5. DATA MANAGEMENT SOFTWARE MARKET
6.5.1. Overview
6.5.2. Data Management Software Market Revenue Forecasts and Analysis (US$ Mn)
6.6. SERVICES MARKET
6.6.1. Overview
6.6.2. Services Market Revenue Forecasts and Analysis (US$ Mn)

7. IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. IMMUNOASSAY/IMMUNOCHEMISTRY MARKET
7.3.1. Overview
7.3.2. Immunoassay/Immunochemistry Market Revenue Forecasts and Analysis (US$ Mn)

7.4. CLINICAL CHEMISTRY MARKET
7.4.1. Overview
7.4.2. Clinical Chemistry Market Revenue Forecasts and Analysis (US$ Mn)
7.5. MOLECULAR DIAGNOSTICS MARKET
7.5.1. Overview
7.5.2. Molecular Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
7.6. MICROBIOLOGY MARKET
7.6.1. Overview
7.6.2. Microbiology Market Revenue Forecasts and Analysis (US$ Mn)
7.7. HEMATOLOGY MARKET
7.7.1. Overview
7.7.2. Hematology Market Revenue Forecasts and Analysis (US$ Mn)
7.8. URINALYSIS MARKET
7.8.1. Overview
7.8.2. Urinalysis Market Revenue Forecasts and Analysis (US$ Mn)
7.9. OTHERS MARKET
7.9.1. Overview
7.9.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

8. IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. DIABETES MARKET
8.3.1. Overview
8.3.2. Diabetes Market Revenue Forecasts and Analysis (US$ Mn)
8.4. INFECTIOUS DISEASES MARKET
8.4.1. Overview
8.4.2. Infectious Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.5. ONCOLOGY MARKET
8.5.1. Overview
8.5.2. Oncology Market Revenue Forecasts and Analysis (US$ Mn)
8.6. CARDIOLOGY MARKET
8.6.1. Overview
8.6.2. Cardiology Market Revenue Forecasts and Analysis (US$ Mn)
8.7. AUTOIMMUNE DISEASES MARKET
8.7.1. Overview
8.7.2. Autoimmune Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.8. NEPHROLOGY MARKET
8.8.1. Overview
8.8.2. Nephrology Market Revenue Forecasts and Analysis (US$ Mn)
8.9. OTHERS MARKET
8.9.1. Overview
8.9.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

9. IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
9.1. OVERVIEW
9.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. HOSPITALS MARKET
9.3.1. Overview
9.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
9.4. LABORATORIES MARKET
9.4.1. Overview
9.4.2. Laboratories Market Revenue Forecasts and Analysis (US$ Mn)
9.5. ACADEMIC INSTITUTES MARKET
9.5.1. Overview
9.5.2. Academic Institutes Market Revenue Forecasts and Analysis (US$ Mn)
9.6. POINT OF CARE TESTING MARKET
9.6.1. Overview
9.6.2. Point of Care Testing Market Revenue Forecasts and Analysis (US$ Mn)
9.7. OTHERS MARKET
9.7.1. Overview
9.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
10. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET OVERVIEW
10.2. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT & SERVICES (US$ MN)
10.4. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.5. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.6. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.7. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.8. US MARKET OVERVIEW
10.8.1. US In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
10.8.2. US In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
10.8.3. US In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
10.8.4. US In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)
10.9. CANADA MARKET OVERVIEW
10.9.1. Canada In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
10.9.2. Canada In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
10.9.3. Canada In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
10.9.4. Canada In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)
10.10. MEXICO MARKET OVERVIEW
10.10.1. Mexico In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
10.10.2. Mexico In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
10.10.3. Mexico In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
10.10.4. Mexico In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)

11. EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. EUROPE IN-VITRO DIAGNOSTICS MARKET OVERVIEW
11.2. EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT & SERVICES (US$ MN)
11.4. EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.5. EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.6. EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.7. EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.8. UK MARKET OVERVIEW
11.8.1. UK In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
11.8.2. UK In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
11.8.3. UK In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
11.8.4. UK In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)
11.9. GERMANY MARKET OVERVIEW
11.9.1. Germany In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
11.9.2. Germany In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
11.9.3. Germany In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
11.9.4. Germany In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)
11.10. FRANCE MARKET OVERVIEW
11.10.1. France In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
11.10.2. France In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
11.10.3. France In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
11.10.4. France In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)

12. ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET OVERVIEW
12.2. ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT & SERVICES (US$ MN)
12.4. ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.5. ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.6. ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.7. ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.8. JAPAN MARKET OVERVIEW
12.8.1. Japan In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
12.8.2. Japan In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
12.8.3. Japan In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
12.8.4. Japan In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)
12.9. CHINA MARKET OVERVIEW
12.9.1. China In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
12.9.2. China In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
12.9.3. China In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
12.9.4. China In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)
12.10. INDIA MARKET OVERVIEW
12.10.1. India In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
12.10.2. India In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
12.10.3. India In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
12.10.4. India In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)

13. MIDDLE EAST AND AFRICA (MEA) IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. MIDDLE EAST AND AFRICA (MEA) IN-VITRO DIAGNOSTICS MARKET OVERVIEW
13.2. MIDDLE EAST AND AFRICA (MEA) IN-VITRO DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST AND AFRICA (MEA) IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT & SERVICES (US$ MN)
13.4. MIDDLE EAST AND AFRICA (MEA) IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.5. MIDDLE EAST AND AFRICA (MEA) IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.6. MIDDLE EAST AND AFRICA (MEA) IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.7. MIDDLE EAST AND AFRICA (MEA) IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.8. UAE MARKET OVERVIEW
13.8.1. UAE In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
13.8.2. UAE In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
13.8.3. UAE In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
13.8.4. UAE In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)
13.9. SAUDI ARABIA MARKET OVERVIEW
13.9.1. Saudi Arabia In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
13.9.2. Saudi Arabia In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
13.9.3. Saudi Arabia In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
13.9.4. Saudi Arabia In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)
13.10. SOUTH AFRICA MARKET OVERVIEW
13.10.1. South Africa In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
13.10.2. South Africa In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
13.10.3. South Africa In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
13.10.4. South Africa In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)

14. SOUTH AND CENTRAL AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA IN-VITRO DIAGNOSTICS MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT & SERVICES (US$ MN)
14.4. SOUTH AND CENTRAL AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
14.5. SOUTH AND CENTRAL AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
14.7. SOUTH AND CENTRAL AMERICA IN-VITRO DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
14.8. BRAZIL MARKET OVERVIEW
14.8.1. Brazil In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Product & Services (US$ Mn)
14.8.2. Brazil In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Technology (US$ Mn)
14.8.3. Brazil In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By Application (US$ Mn)
14.8.4. Brazil In-Vitro Diagnostics Market Revenue and Forecasts Analysis - By End User (US$ Mn)

15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Product Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions

16. IN-VITRO DIAGNOSTICS MARKET, KEY COMPANY PROFILES
16.1. F. HOFFMANN-LA ROCHE LTD
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product Portfolio
16.1.5. SWOT Analysis
16.1.6. Key Developments
16.2. DANAHER
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product Portfolio
16.2.5. SWOT Analysis
16.2.6. Key Developments
16.3. BD
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product Portfolio
16.3.5. SWOT Analysis
16.3.6. Key Developments

16.4. ABBOTT
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product Portfolio
16.4.5. SWOT Analysis
16.4.6. Key Developments
16.5. SIEMENS AG
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product Portfolio
16.5.5. SWOT Analysis
16.5.6. Key Developments
16.6. BIOMÉRIEUX SA
16.6.1. Key Facts
16.6.2. Business Description
16.6.3. Financial Overview
16.6.4. Product Portfolio
16.6.5. SWOT Analysis
16.6.6. Key Developments
16.7. THERMO FISHER SCIENTIFIC INC.
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product Portfolio
16.7.5. SWOT Analysis
16.7.6. Key Developments
16.8. BIO-RAD LABORATORIES, INC.
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product Portfolio
16.8.5. SWOT Analysis
16.8.6. Key Developments
16.9. AGILENT TECHNOLOGIES, INC.
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product Portfolio
16.9.5. SWOT Analysis
16.9.6. Key Developments
16.10. JOHNSON & JOHNSON SERVICES, INC.
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product Portfolio
16.10.5. SWOT Analysis
16.10.6. Key Developments

17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
The List of Companies

1. F. Hoffmann-La Roche Ltd
2. Danaher
3. BD
4. Abbott
5. Siemens AG
6. bioMérieux SA
7. Thermo Fisher Scientific Inc.
8. Bio-Rad Laboratories, Inc.
9. Agilent Technologies, Inc.
10. Johnson & Johnson Services, Inc.